ArticleFrontiers in pharmacology2024
Duvelisib is a novel NFAT inhibitor that mitigates adalimumab-induced immunogenicity.
Aboli Bhingarkar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleFrontiers in pharmacology2024
Aboli Bhingarkar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.